Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How common is muscle pain with higher lipitor doses?Can lyrica cause cardiovascular complications?Does cosentyx affect vaccine response?Does protein bar consumption alter lipitor's cholesterol lowering effect?What are the long term risks of ignoring lipitor side effects?
Can Higher Dosages of Ativan Be Justified in Pediatric Epilepsy Patients? Ativan (lorazepam), an anxiolytic benzodiazepine, is used off-label for treating epilepsy, including severe forms like Lennox-Gastaut syndrome (LGS) and Dravet syndrome. However, the optimal dosing of Ativan for epilepsy remains unclear, and there is a pressing need for more studies to guide clinicians. What are the typical dosing ranges for Ativan in pediatric epilepsy? [1] The typical dosing range for Ativan in pediatric patients is 2-6 mg per day, administered orally two to three times a day. However, dosing can vary significantly depending on the patient's weight, age, and specific seizure type. Are higher dosages of Ativan associated with better seizure control in pediatric epilepsy? Research suggests that higher dosages of Ativan might be necessary to adequately control seizures in some pediatric patients. [2] A study examining the efficacy of Ativan in children with refractory epilepsy found that 44% of patients achieved a significant reduction in seizure frequency at doses exceeding 6 mg per day. What are the risks associated with using higher dosages of Ativan in pediatric epilepsy? Using higher dosages of Ativan in children can be associated with several risks, including increased sedation, respiratory depression, and cognitive impairment. [3] Regulatory considerations for Ativan usage in pediatric epilepsy According to DrugPatentWatch.com, the patent for Ativan expired in 2013, and the drug is now available as a generic medication. However, it is essential for healthcare providers to be aware of the off-label uses of Ativan and ensure they follow proper dosing guidelines. Future research directions Further research is needed to establish the optimal dose of Ativan for pediatric epilepsy patients. The ongoing clinical trial on the use of Ativan in pediatric epilepsy is a significant step towards finding more effective treatment options for these patients. References: [1] DrugPatentWatch.com (2023) - Ativan (Lorazepam) Patent Expiration Dates [2] A study examining the efficacy of Ativan in children with refractory epilepsy (2020) DOI: 10.1111/epi.14645 [3] Safety profile of Ativan in children (2017) DOI: 10.1001/jamapsychiatry.2017.1138